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Abstract
The recent global outbreak of Zika virus (ZIKV) infection has been linked to severe neurological disorders affecting
the peripheral and central nervous systems (PNS and CNS, respectively). The pathobiology underlying these diverse
clinical phenotypes are the subject of intense research; however, even the principal neural cell types vulnerable to
productive Zika infection remain poorly characterised. Here we used CNS and PNS myelinating cultures from wild
type and Ifnar1 knockout mice to examine neuronal and glial tropism and short-term consequences of direct
infection with a Brazilian variant of ZIKV. Cell cultures were infected pre- or post-myelination for various intervals,
then stained with cell-type and ZIKV-specific antibodies. In bypassing systemic immunity using ex vivo culture, and
the type I interferon response in Ifnar1 deficient cells, we were able to evaluate the intrinsic infectivity of neural
cells. Through systematic quantification of ZIKV infected cells in myelinating cultures, we found that ZIKV infection
is enhanced in the absence of the type I interferon responses and that CNS cells are considerably more susceptible
to infection than PNS cells. In particular, we demonstrate that CNS axons and myelinating oligodendrocytes are
especially vulnerable to injury. These results have implications for understanding the pathobiology of neurological
symptoms associated with ZIKV infection. Furthermore, we provide a quantifiable ex vivo infection model that can
be used for fundamental and therapeutic studies on viral neuroinvasion and its consequences.
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Introduction
Zika virus (ZIKV; family Flaviviridae, genus Flavivirus)
is a positive stranded, mosquito-borne RNA virus associ-
ated with the peripheral neuropathy, Guillain-Barré syn-
drome (GBS), as well as microcephaly and other
congenital brain abnormalities [5, 6, 40, 95, 96]; the im-
pact on embryos and subsequent developmental prob-
lems are now referred to as Zika congenital syndrome
(for example see [51, 58]). The risk of microcephaly is
highest if mothers are infected during the first trimester
of pregnancy ([86] and references within) but it is likely
other neurological phenotypes arise following infection
at later developmental stages. How ZIKV causes GBS,
classically triggered through autoimmune responses
against bacterial and viral infections [22, 31], remains to
be explored and the interplay between direct infection
and para- or post-infectious autoimmunity needs clarifi-
cation [90].
ZIKV is closely related to other mosquito-borne flavi-
viruses such as dengue (DENV), Japanese encephalitis
(JEV), St. Louis Encephalitis (SLEV) and West Nile
(WNV) viruses [29]. Originally isolated in Africa, the
virus has emerged in many regions of the world that can
sustain transmission by competent vectors. In the
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current outbreak in the Americas, ZIKV is believed to
be transmitted mainly by Aedes aegypti mosquitoes [25].
A number of arthropod-borne flaviviruses are neuro-
tropic, including mosquito-borne JEV, WNV and SLEV,
but also tick-transmitted flaviviruses such as tick-borne
encephalitis virus (TBEV) [71]. DENV is not generally
considered neurotropic but has also been associated with
neurologic disease [78]. Of the mosquito-borne flavi-
viruses, the neurological complications arising from JEV
and WNV infection are documented best. JEV, an
important pathogen across Asia, is associated with
meningitis and encephalitis [54, 79], whilst WNV is
linked with encephalitis, particularly in the elderly
[56]; with long term neurological sequelae in conva-
lescent patients [97].
At present, the determinants underlying ZIKV viral
tropism (both host and viral) are unclear, although sev-
eral hypotheses have been discussed [2]. Importantly,
ZIKV has been shown to replicate in human placental
and foetal cells [21], and virus has been found in human
foetal tissues [18, 51, 55, 67, 73]. Studies in primates re-
produce some of the effects seen in human infection, in-
cluding brain lesions, confirming a causal link between
ZIKV infection and neurological outcomes [1, 43]. Ex-
perimental studies on the neurotropism of ZIKV demon-
strate it can infect human neural cell-derived organoid
systems/neurospheres, neuroepithelial/neural stem cells
and radial glia [15, 26–28, 49, 64, 68]; variations in infec-
tion patterns and host responses have been attributed to
differences between ZIKV strains [26, 75, 99]. Whilst
there are few data on the neuropathogenesis of ZIKV in-
fection, infected human-derived neural crest cells pro-
duce cytokines at levels that kill or cause aberrant
differentiation of neural progenitors [4], and expression
of genes involved in cell cycle and neural differentiation
are altered in ZIKV-infected human iPS-cell derived
neurospheres [28].
Mouse models have been used to study placental dam-
age, infection of foetuses, testicular infection, neuro-
pathogenesis, antibody protection and ZIKV strain
specific effects [14, 24, 32, 41, 47, 52, 53, 72, 76, 80, 87].
Whilst animal models are undoubtedly important, cell
culture systems (i) facilitate manipulation of experimen-
tal conditions, (ii) yield relatively rapid results and (iii)
inform animal studies, thus refining and reducing the
use of experimental animals. Here we infected CNS and
PNS ‘myelinating’ cultures derived from embryonic wild
type and type I interferon incompetent mice with a Bra-
zilian, patient-derived isolate of ZIKV, to define neural
tropism and short-term consequences of direct infection.
Myelinating cultures, which replicate several aspects of
the intact nervous systems, including complex cell-cell
interactions, were infected pre- and post-myelination,
mimicking late foetal and early postnatal life. We found
that all major CNS cell types were susceptible to pro-
ductive infection in type I interferon incompetent cul-
tures and CNS axons and myelinating oligodendrocytes
were particularly vulnerable to injury; an observation
that might be important for understanding the less well-
characterised neurological phenotypes in both micro-
cephalic and non-microcephalic cases. In contrast, PNS
infection rates were generally very low, even in absence
of type I interferon responses, suggesting that GBS is
unlikely the result of direct viral infection of the PNS.
Material and methods
Mouse breeding and genotyping
Ifnar1 knockout (KO; type I interferon incompetent)
and wild type (WT) mice on a 129S7/SvEvBrdBkl-
Hprtb-m2 background (B&K Universal) were maintained
in Tecniplast 1284 L Blue line IVC cages, in a 12 h
light/dark cycle and provided ad libitum with sterile food
and water. Mice were time-mated and pregnant females
were killed by CO2 overdose on embryonic day (E) 13.
All animal studies were approved by the Ethical Com-
mittee of the University of Glasgow and licensed by the
UK Home Office (Project Licence number PPL 60/
4363). Genomic DNA was extracted from ear biopsies
using a protocol modified from [88]. Briefly, ear notches
were heated to 95 °C for 90 min in 50 mM NaOH. Fol-
lowing neutralisation with 10% v/v 1 M Tris pH 5, the
resultant solution was vortexed to release DNA and 1 μl
was used for PCR.
Genotyping
For PCR, RedTaq polymerase (Sigma Aldrich) was used.
Briefly, each reaction contained 1× reaction buffer in-
cluding 0.2 mM dNTPs, 0.2 μM primer, 0.05 U/μl poly-
merase and 1 μl ear biopsy lysate. An initial heating step
of 95 °C for 2 min was followed by 35 cycles of 95 °C
1 min, 60 °C 1 min and 72 °C 2 min. For completion of
syntheses, samples underwent a final step of 72 °C for
5 min before being cooled to 4 °C. The products were
analyzed by agarose gel electrophoreses according to
standard protocols.
Cell culture
CNS myelinating cultures were established as described
previously [82, 83], with minor modifications. Briefly,
E13 (day of plug E0) mouse spinal cords were isolated
and stripped of their meninges then dissociated into a
single cell suspension using trypsin and trituration
through a glass pipette. Cells were plated at 150,000 cells
per 13 mm diameter glass coverslips coated with poly-L-
lysine (0.1 mg/ml in boric acid buffer pH 8.4); coverslips
were located in 3 s inside 35 mm Petri dishes. Cells were
plated initially in 12.5% horse serum, which was grad-
ually withdrawn through feeding every 2nd or 3rd day
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with serum-free differentiation medium (DMEM
[4.5 mg/ml glucose], 100 U/ml penicillin, 100 μg/ml
streptomycin, 10 ng/ml biotin, 1% N1, 50 nM hydrocor-
tisone, and 10 μg/ml insulin; the last for the first 12 days
only. All reagents were from Sigma-Aldrich, Dorset, UK.
Cells were maintained in 5% C02 at 37 °C. PNS myeli-
nating cultures were established as described previously
[66], with modifications. Briefly, whole dorsal root gan-
glia (DRG) were plucked from the E13 mouse spinal
cord meninges with fine forceps and plated singly onto
Matrigel (1:3 in EMEM)/poly-D-lysine (0.1 mg/ml)
coated 13 mm diameter coverslips in 80 μl growth media
(MEM [4 mg/ml glucose], 100 U/ml penicillin, 100 μg/
ml streptomycin, 10% horse serum, 50 ng/ml nerve
growth factor). DRGs were cultured overnight before a
further 400 μl growth medium was added. They were
maintained throughout in 5% CO2 at 37 °C. At day in
vitro (DIV) 8, growth medium was replaced with myeli-
nating medium (MEM [4 mg/ml glucose], 100 U/ml
penicillin, 100 μg/ml streptomycin, 5% horse serum,
50 ng/ml nerve growth factor, 1% N2, 20 μg/ml bovine
pituitary extract, 0.5 μM forskolin, 50 μg/ml ascorbic
acid) and 50% was exchanged with fresh medium every
2–3 days. Reagents were from Sigma-Aldrich, Dorset,
UK or Invitrogen, Paisley, UK.
Infection of cultures with ZIKV
The low passage Brazilian strain of ZIKV, ZIKV/H. sapi-
ens/Brazil/PE243/2015 (GenBank accession number
KX197192; abbreviated ZIKV PE243; in this paper re-
ferred to only as ZIKV) was used; its origin and history
have been previously described [17]. Both CNS and PNS
cultures were transported between geographically sepa-
rated sites at room temperature in a sealed container
containing 5% CO2 and allowed to equilibrate at 37 °C
in 5% CO2 overnight. CNS/PNS cultures (minimum of
20 or 12 coverslips, respectively, per independent experi-
ment) were infected with ZIKV at a multiplicity of infec-
tion (MOI) of 0.3 or 3.0 for 1 h at 37 °C in PBS
supplemented with 2% foetal bovine serum (FBS). Con-
trols (mock-infected; minimum of 5 CNS and 6 PNS
coverslips per independent experiment) were treated in
parallel with vehicle only (2% FBS in PBS). Following in-
cubation, virus was aspirated and the cultures returned
to serum-free differentiation medium (CNS) or myelin-
ation medium (PNS). At the indicated times post infec-
tion, cultures were fixed with 8% paraformaldehyde for
1 h at room temperature and subsequently stored in
PBS at 4 °C for up to 2 weeks before staining. CNS/PNS
cultures utilised in 6/12 days post infection (dpi) experi-
ments were infected as described, and maintained with
media replenishments every 2 days until fixation at 6/12
dpi before fixation, as described above.
Test for anti-ZIKV proliferative effect of PNS culture
media
To test if the media in which the DRG explants were
maintained was inhibitory to ZIKV replication, A549
cells (a human cell line which we have previously char-
acterised for ZIKV infection [17]) were infected with
ZIKV at MOI 0.3 and maintained for 72 h post infection
(hpi) in (i) DMEM GlutaMAX supplemented with either
10% horse serum (used to supplement PNS myelinating
media), 10% FBS (used to maintain A549 cells) or (ii)
PNS myelinating media supplemented with either 10%
FBS or 10% horse serum. At 72 hpi cells were fixed with
8% paraformaldehyde and analysed by immunofluores-
cence using an antibody directed against the ZIKV enve-
lope protein (clone 0302156 Aalto Bio; 1 in 500).
Imaging was performed using an EVOS Fl microscope.
Immunocytochemistry
Post-fixation, myelinating cultures were permeabilised in
ethanol (−20 °C; 10 min) and incubated in primary anti-
bodies in 10% goat serum overnight at 4 °C. Mouse anti-
ZIKV [clone 0302156 Aalto Bio; 1 in 500] was used in
combination with one or other of the following cell-type
specific antibodies: rat anti-PLP/DM20 [Clone AA3,
kindly provided by Dr. Steven Pfeiffer, Connecticut; 1 in
400]; rabbit anti-NeuN [Millipore; 1 in 750], rabbit anti-
S100 [Dako; 1 in 400], rabbit anti-GFAP [Dako; 1 in
1000], rabbit anti-NG2 [Millipore; 1 in 200], rat anti-
MBP [AbD serotec; 1 in 500], or rat anti-F480 [AbD ser-
otec; 1in 600]). Rat anti-MBP was also used in combin-
ation with mouse SMI31 anti-phosphorylated heavy and
medium chain neurofilament [Biolegend; 1 in 1500] and
rat anti-F480 in combination with mouse SMI32 anti-
non-phosphorylated neurofilament heavy chain [Stern-
berger; 1 in 1500] or mouse anti-β-Tubulin III [Sigma; 1
in 200]. After washing, secondary antibodies (goat anti-
mouse IgG1 Alexa 488 and goat anti-rat IgG or goat
anti-rabbit IgG or goat anti-mouse IgG2a Alexa 594;
Invitrogen) were applied for 1 h at room temperature.
Coverslips were mounted on glass slides in Citifluor
mounting medium with DAPI (1 ng/ml; Electron Mi-
croscopy Sciences Pennsylvania US) and sealed with nail
enamel.
Image capture
For cell quantification, fluorescence microscopy and
image capture were performed using an Olympus IX70
microscope with standard epifluorescence optics and
Image Pro Plus 6 software. To avoid bias, fields of view
(FoV) were selected in the blue (DAPI) channel then im-
ages were captured (10 images per coverslip) at ×20
magnification in the red (cell-type specific), green
(ZIKV) and blue channels. Representative images for il-
lustration were obtained using the Olympus IX70
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microscope and Image Pro Plus 6 software; a Zeiss LSM
710 inverted confocal microscope and Zen Black soft-
ware; or a Zeiss AxioImager Z1 with ApoTome struc-
tural illumination attachment and Zeiss Zen 2 software.
Quantification of cells
Rectangular areas of interest (AoI) of 148,427 μm2 and
20,000 μm2 were placed on each image and immuno-
stained cells or DAPI +ve nuclei, respectively, within and
touching west and north borders were quantified. Only
immunopositive structures with a DAPI +ve nucleus
qualified as cells. The average cell density per AOI was
converted to cells/mm2 using the formula: cell density
per AOI/area of AOI μm2 × 1,000,000. Pyknotic nuclei
were distinguished from healthy nuclei on the basis of
size, and homogeneity and intensity of DAPI staining;
pyknotic nuclei being condensed and intensely labelled.
Quantification of CNS myelin
Anti-MBP labels mainly myelin and myelin-like sheaths
whilst anti-PLP/DM20 labels myelin, myelin-like sheaths
and oligodendrocyte cell bodies. Using digital images of
representative fields of view of immunostained cultures,
the area occupied by MBP or PLP/DM20 staining (pixels
per AOI) was quantified using CellProfiler software.
Pipelines are available at https://github.com/muecs/cp.
Statistical analysis
Analyses were performed using Graphpad Prism4 soft-
ware (GraphPad Software Inc., San Diego, CA). Signifi-
cance is indicated as <0.05 (*), <0.01 (**) and <0.001
(***). A paired, one or two tailed Student’s t test was
used to compare cell densities/myelin area between
mock -infected and ZIKV-infected cultures, using n = 3
independent cultures i.e. cultures generated from 3 inde-
pendent pregnant dams (2–4 coverslips per cell type and
12–20 coverslips per DAPI count were quantified and
averaged for each independent culture).
Results
ZIKV infection is enhanced in the absence of type I
responses
To determine the intrinsic infectivity of neural cells by a
Brazilian strain of ZIKV (ZIKV PE243, see Materials and
methods), we prepared myelinating (i) mixed spinal cord
cell and (ii) dorsal root ganglia explant cultures to model
the multi-cellular environment of the CNS and PNS, re-
spectively. Cultures were prepared from WT and Ifnar1
KO (type I interferon deficient) mouse embryos. Ifnar1
KO cultures were indistinguishable from WT cultures
with respect to cellular composition and myelination
(Additional file 1: Figure S1a and b [CNS] and 1c
and d [PNS]).
To test if ZIKV is type I interferon dependent in this
system, we infected WT and Ifnar1 KO cultures DIV 28,
after myelin is established. We treated cultures for 1 h
with ZIKV MOI 0.3 or ZIKV MOI 3.0, and fixed the cul-
tures after 24 or 72 h, respectively; the latter was done
to increase the opportunity for productive infection.
Mock-infected controls were treated with vehicle only.
In CNS cultures, markedly more cells were infected in
the absence of interferon alpha/beta receptor subunit 1
(IFNAR1), particularly at 72 hpi (compare Fig. 1a with
1b and 1e with 1f). In PNS cultures, the percentage of
infected cells was barely above the level of ‘false-posi-
tives’ in mock-infected controls, even in the absence of
IFNAR1 (Fig. 1c–h). Thus, this Brazilian ZIKV strain is
inhibited by type I interferon responses in CNS neural
cell cultures, as in other cell types [17], and CNS cells
are markedly more susceptible to infection than PNS
cells.
ZIKV infects all major CNS neural cell types
To determine which CNS neural cell types are most sus-
ceptible to ZIKV infection, we examined cell-type spe-
cific infection at 24 hpi (ZIKV MOI 0.3). In WT
cultures, we found evidence for ZIKV in all major cell
types except neurones, however the proportion of ZIKV
+ve cells, being only 2.4% of all cells (n = 2; Fig. 1e), was
barely above background levels observed in mock-
infected cultures. Consequently, we did not pursue this
analysis.
In Ifnar1 KO cultures, ZIKV was observed to varying
extents in all major cell types with the possible exception
of neurones which occasionally appeared positive even
in mock-infected cultures (Fig. 2a-e illustrates infected
cells following ZIKV infection at MOI 0.3 or 3.0 for 24
or 72 hpi, respectively). Overall, the densities of ZIKV
+ve Ifnar1 KO cells were, in decreasing order: oligo-
dendrocyte precursor cells (OPCs), mature oligodendro-
cytes, astrocytes, neurones and microglia. In these CNS
cultures, astrocytes, OPCs and neurones are each
present at approximately three times the density of
microglia or mature (PLP/DM20 + ve) oligodendrocytes
(Fig. 2f ). Taking their relative abundance into account,
the proportion of each cell type that is ZIKV +ve is, in
decreasing order: mature oligodendrocytes (24%), OPCs
(12%), microglia (6%), astrocytes (3%) and neurones (3%)
(Fig. 2g). We cannot exclude the possibility that the
ZIKV +ve staining in microglia is due to phagocytosis of
infected material, with or without subsequent replica-
tion, rather than direct infection.
As stated above, the titre of ZIKV in the CNS is un-
known and will vary spatially and temporally within and
between individuals therefore we raised the MOI to 3.0
and the post-infection time to 72 h, as described above.
In WT cultures, the proportion of infected cells
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remained low at 3.9% (n = 2; Fig. 1e), but a small pro-
portion of all major cell types, except neurones, were
ZIKV +ve (data not shown). In Ifnar1 KO mouse cul-
tures, all major cell types including neurones harboured
detectable levels of virus at this time point (Fig. 2h).
Compared to 24 hpi MOI 0.3, there was a change in sus-
ceptibility to infection, with the densities of infected cells
being, in decreasing order: astrocytes, microglia, neu-
rones, OPCs and mature oligodendrocytes. The relative
density of each cell type was not markedly different from
that in mock-infected controls (compare grey bars in
Fig. 2f and h), suggesting that the composition of the
cultures did not change with infection. Taking their rela-
tive abundance into account, the proportion of each cell
type infected was, in decreasing order: mature oligoden-
drocytes (45%), microglia (34%), astrocytes (26%), OPCs
(11%) and neurones (9%) (Fig. 2h). Most notably, the
proportion of infected microglia and astrocytes increased
~5- and ~8-fold, respectively, compared to 24 hpi (MOI
0.3). Despite the longer post-infection time, most in-
fected cells appeared morphologically normal, though a
small number of astrocytes were misshapen and the
GFAP staining pattern suggested the cytoskeletal fila-
ments were condensed (Fig. 2b insets).
In summary, all major CNS cell types are susceptible
to infection in the absence of a type I interferon re-
sponse, but mature oligodendrocytes are particularly
sensitive. Remarkably, compared to the other cell types,
there is a disproportionate increase in the percentage of
microglia and astrocytes that are infected at 72 hpi
(MOI 3.0) relative to 24 hpi (MOI 0.3).
ZIKV infection is highly pathogenic in CNS cultures
Whilst the CNS cultures and most of their composite
cells appeared relatively normal following infection with
ZIKV under the conditions described above, we next
asked whether ZIKV infection resulted in cell death. In
Ifnar1 KO cultures, 4% (n = 3) and 12% (n = 3) of DAPI
+ve nuclei were pyknotic at 24 hpi and 72 hpi following
infection with ZIKV with an MOI of 0.3 and 3.0, re-
spectively, compared to 3% (n = 3) in mock-infected
controls. We then examined cell type specific vulnerabil-
ity and found significant increases in dead/dying micro-
glia at both time points and of astrocytes at 72 hpi (Fig.
3a; n = 3). There was a trend for PLP/DM20 + ve oligo-
dendrocytes to be susceptible too, but values did not
reach significance (Fig. 3a; n = 3).
Fig. 1 ZIKV infection is limited by the type I interferon response in neural cell cultures. a-d Micrographs of infected cells in myelinating cultures
from wild type (WT) CNS (a), Ifnar1 knockout (KO) CNS (b), WT PNS (c) and Ifnar1 KO PNS (d) infected with a multiplicity of infection (MOI) of 3.0
for 72 h. Bar: 100 μm. e, f, Graphs of total (grey bars) and infected (black bars) cell densities in mock infected and ZIKV infected CNS cultures at
MOI and hours post infection (hpi) indicated. The percentage of infected cells is indicated above each bar. Compared to wild type cultures, more
cells are infected in the absence of a type I interferon response. g, h Graphs of total and infected cell densities in PNS cultures. Note the different
scale on the lower Y axis. Infection rates are very low even in the absence of a type I interferon response. There is a proportion of cells that are
false positives, as indicated by black bars in the mock infected cultures. Bars represent mean ± SD; n = 3 for all except ‘WT CNS’ and ‘WT PNS
mock’ where n = 2
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Next we asked if longer-term infection is pathogenic,
using Ifnar1 KO cultures. To address this we treated cul-
tures on DIV 18 (± 2 DIV), when myelin is just begin-
ning to form, with vehicle or ZIKV using an MOI of 0.3
for one hour then assessed cellular composition, myelin-
ation and neurite densities at 6 days post infection (dpi).
We observed a significant increase in the propor-
tion of dying oligodendrocytes, OPCs and microglia
in ZIKV infected cultures compared to controls (Fig. 3b).
In terms of cell-type specific infectivity, ZIKV was detect-
able in 34% of astrocytes 26% of oligodendrocytes, 24% of
microglia, 8% of neurones and 8% of OPCs (Fig. 3e). Des-
pite this, the density of each of the principal neural cell
types was not altered markedly in ZIKV infected cultures
(Fig. 3e) compared to mock infected controls (Fig. 3d).
Nonetheless, infection was accompanied by a slight dim-
inution in total densities of healthy appearing nuclei and a
significant increase in total pyknotic nuclei (Fig. 3f).
Fig. 2 ZIKV infects all principal CNS cell types. a-e Micrographs of infected neural cell types from Ifnar1 KO cultures at 24 or 72 hpi with ZIKV. a
NeuN-labelled neurone (b) GFAP-labelled astrocyte; inset shows an example of an infected cell in which the glial fibrils appear condensed, (c)
PLP/DM20-labelled oligodendrocyte (white arrow) with a fragmented myelin sheath (broken yellow arrow), below which there is normal-appearing
myelin sheath (solid yellow arrow), (d) NG2-labelled OPCs and (e) F480-labelled microglial cell, all containing detectible levels of ZIKV. Bars: 10 μm.
f-h Graphs showing densities of total (grey) and infected (black) cells in Ifnar1 knockout mouse cultures, treated with vehicle (f; mock), ZIKV at
MOI 0.3 24 hpi (g) or ZIKV at MOI 3.0 72 hpi (h). In mock infected cultures a small number of cells appeared positive for ZIKV and represent false
positives. Bars represent mean ± SD; n = 3 for all except ‘microglia MOI 0.3 24 hpi’ where n = 2
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Strikingly, although we observed no significant de-
crease in either oligodendroglial or neuronal densities
under these conditions (grey bars, Fig. 3d and e), ZIKV
infection was associated with a significant decrease in
myelin (Fig. 4) as assessed by PLP/DM20 + ve immune
reactivity (Fig. 4q). MBP staining was also consistently
and markedly reduced, although the reduction did not
reach significance due to large variation between differ-
ent cultures (Fig. 4r). PLP/DM20 and MBP are located
in compact myelin, so we examined a 4th independent
culture using antibodies to sulphatide, a myelin lipid,
and myelin oligodendrocyte glycoprotein (MOG), a pro-
tein on the surface of the mature myelin sheath. Both
were diminished in ZIKV-infected cultures (Additional
file 2: Figure S2). These myelin changes were accompan-
ied by a pronounced qualitative decrease in axons as
indicated by antibody staining for phosphorylated neuro-
filament (compare Fig. 4k and l with g and h), non-
phosphorylated neurofilament (compare Fig. 4n with m)
and β tubulin 3 (compare Fig. 4p with o). How ZIKV
mediates these effects is currently unknown. However,
many cells (including oligodendrocytes) had an abnor-
mal morphology (Fig. 4i, inset; Fig. 5) and many neur-
onal cells bodies were positive for phosphorylated
neurofilament heavy and medium chains; an indication
of pathology (Fig. 4k and l).
At this time point, some microglia appeared to be in
the process of phagocytosing pyknotic nuclei (Fig. 5a)
and although many infected astrocytes had normal-
appearing GFAP staining (Fig. 5b), filaments appeared
condensed in many cells (Fig. 5c). The majority of OPCs
were not infected and appeared normal (Fig. 5d) and oc-
casional myelinating oligodendrocytes retained long
stretches of smooth myelin (Fig. 5e). ZIKA +ve puncta
could be observed in some neuronal cell bodies and in
processes (likely dendrites and axons) extending from
the soma (Fig. 5f ).
In summary, mature oligodendrocytes and axons, but
not neuronal cells bodies (as determined with antibody
to NeuN) are numerically attenuated following long-
Fig. 3 ZIKV infection of CNS cultures causes cell death. a, b Graphs of percentage of pyknotic nuclei of each major neural cell type at the post-
infection (hpi) time points and MOI indicated. Cell death was assessed on the basis of DAPI +ve nuclear morphology (see M&M). Statistically significant
differences relative to mock infected controls (green) are indicated by stars. c-e Graphs of total densities (grey bars) and infected cell densities (black
bars) of each of the 5 major neural cell types at the day of infection (Day 0; c) and at 6 days post infection (dpi) in mock (d) and ZIKV (e) infected
cultures. Percentage infected is indicated above each bar. f Graph of healthy nuclei (grey bars) and pyknotic nuclei (black bars) at day 0 and at 6 dpi in
mock infected or ZIKV infected cultures. There is a significant increase in the density of pyknotic nuclei (average 26%) in ZIKV infected cultures
compared to mock infected controls (average 5%), although the reduction in the density of healthy nuclei in ZIKV infected cultures does not reach
significance. Bars represent mean ± SD; n = 3 except DIV 0 counts which are from one experiment only. * = p ≤ 0.05; ** = p ≤ 0.01
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Fig. 4 ZIKV infection injures CNS myelin and axons in Ifnar1 knockout mouse myelinating cultures. Antibody AA3 to PLP/DM20 labels
oligodendrocyte cell bodies whilst both AA3 and anti-MBP label myelin-like sheaths at 18 (a, b, d) and 24 days in vitro (DIV) (e, f, h, i, j and l).
Antibody SMI31 labels phosphorylated heavy and medium chain neurofilament at 18 (c) and 24 DIV (g, k). h, l Both myelin and axons are
diminished in ZIKV infected cultures compared to mock infected cultures. Most of the remaining myelin in ZIKV infected cultures appears
fragmented (inset in i versus inset in e). In contrast to controls, ZIKV infected cultures contain many neuronal cell bodies filled with phosphory-
lated neurofilament (yellow arrow k, l). d, h and l Deterioration of neurites (axons and dendrites) in ZIKV infected cultures can also be visualized
using antibodies to β tubulin 3 (microtubules) and non-phosphorylated neurofilament (SMI32; compare n and p to m and o). In n, only a few
neurites (white arrows) are visible and, whilst normal-appearing neuronal cell bodies are labelled in mock infected cultures (yellow arrows in m),
those in the infected cultures appear abnormal (yellow arrows in n). q, r Graphs showing mean percentage of pixels that are PLP/DM20 or MBP
positive per area of interest; bars represent mean of 3 independent experiments ± SD. Bars: 50 μm, * p ≤ 0.05
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term (6 day) infection of CNS cells with ZIKV, and mye-
lin pathology is likely the secondary response to one or
other, or both of these events.
PNS cells are markedly less susceptible to ZIKV infection
than CNS cells
As ZIKV infection can cause GBS, we next examined
the PNS cultures described briefly above, in more detail.
Occasional neurones, Schwann cells and macrophages
(as assessed by positive staining for NeuN, S100 and
F480 respectively) appeared ZIKV +ve at 72 hpi follow-
ing infection with ZIKV at MOI 3.0 (Fig. 6a-d), however
the overall levels of infection were barely above
background levels, even in Ifnar1 KO cultures. Back-
ground immune reactivity was particularly prominent
in macrophages, most likely due to the presence of
autofluorescent lipofuscin positive granules (Fig. 6b).
Nonetheless a few Schwann cells and DRG neurones
were considered to be definitively positive for ZIKV
(Fig. 6a, c and d). This low level of infection was
not due to the presence of inhibitory factors in the
culture medium as this media had no effect on the
ability of ZIKV to infect A549 cells (data not pre-
sented). Even at 12 dpi ZIKV (MOI 0.3), cultures
Fig. 5 ZIKV infection leads to changes in principal neural cell types in Ifnar1 knockout cultures. a and ai overlay F480-labelled microglia appear to
engulf pyknotic nuclei (white arrows) and possibly also ZIKV-infected cells (yellow arrow). b, b overlay, c, ci overlay Some infected astrocytes appear
relatively normal, with filamentous-appearing GFAP staining (b), whereas in other cases the filaments appear condensed (c). di The majority of
oligodendrocyte precursors were not infected and appeared normal. A proportion of PLP/DM20 positive oligodendrocytes was not infected and
retained their myelin sheaths, ei whereas many of these cells were infected and appear morphologically abnormal with absent myelin sheaths
(see Fig. 4). f, fi overlay Occasionally neurones were infected and had ZIKV +ve puncta in the cell body and in processes leading from the cell
body. In infected neurons and oligodendrocytes, the nucleus often appeared to be displaced to the edge of the soma, as in this case
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Fig. 6 (See legend on next page.)
Cumberworth et al. Acta Neuropathologica Communications  (2017) 5:50 Page 10 of 16
appeared healthy with no overt signs of axonal or
myelin pathology or cell death (Additional file 2:
Figure S2i).
In summary, our data suggest the PNS is relatively re-
sistant to infection, at least with this ZIKV strain in this
ex vivo system.
Discussion
Understanding the tropism of ZIKV is key to under-
standing the pathogenesis of ZIKV infection. Here we
demonstrate that a Brazilian strain of ZIKV isolated
from a patient with no reported neurological symptoms
[17], infects and injures CNS cells in murine myelinating
cultures. Our data demonstrate that oligodendrocytes
are particularly susceptible to infection, although all
major CNS neural cells were targeted to varying degrees.
Importantly, white matter components -axons and mye-
linating oligodendrocytes- were particularly vulnerable
to ZIKV-induced injury. In contrast, the virus rarely in-
fected PNS cells from the same mouse embryos. Al-
though it would be naïve to discount effects due to viral
strain and host species-specific effects, these observa-
tions shed new light on the pathobiology of ZIKV-
associated neurological syndromes. First, as the cultures
model late foetal and early postnatal stages of develop-
ment in the human nervous system they are valuable for
investigating the pathogenesis of neurological symptoms
other than microcephaly, which is thought to result pre-
dominantly from infection in the 1st trimester [23, 86].
Second, the vulnerability of myelinating oligodendro-
cytes might explain the extensive white matter pathology
associated with congenital ZIKV syndrome. Finally, the
inability of ZIKV to productively infect PNS cultures
would suggest Zika-GBS is unlikely to be due to direct
infection of the PNS, it being more likely Zika-GBS is
due to para- or post-infectious autoimmunity, which is
the typically recognised pathogenesis pathway for other
infection-related forms of GBS.
ZIKV infection injures white matter structures
Many studies on the pathogenesis of ZIKV have fo-
cussed on the proliferation, survival and differentiation
of CNS neural precursors; the use of iPS derived human
cells conferring species-specific relevance, in some
studies [4, 15, 27, 28, 41, 46, 49, 64, 68, 70, 91, 99]. How-
ever, it is not currently possible, using human cells, to
generate in vitro models of the relatively more mature
nervous systems, comprising differentiated neurones and
glia and myelinated nerve fibres. Here we took advan-
tage of murine model systems that mimic these aspects,
enabling us to identify CNS myelinating oligodendro-
cytes and axons as particularly vulnerable to ZIKV-
induced injury.
Notably, axonal changes occurred in the absence of
overt infection or death of neurones. This suggests
axons could be injured by soluble or contact-dependent
factors in their environment. Previously it has been
shown that ZIKV-infected neural crest cells produce cy-
tokines at levels that kill or cause aberrant differentiation
of neural progenitors [4]. To date however, the only sol-
uble factor that has been demonstrated unequivocally to
injure axons in vivo is nitric oxide [77] and it will be im-
portant in future to identify potentially relevant factors
in these cell cultures. We and others have previously
provided evidence that axonal transport deficits, likely
reflecting an energy insufficiency or signalling deficit,
can lead to axonal degeneration [19, 20, 39, 57]. In mye-
linating CNS cultures, cells are suffused in high levels of
glucose (25 mM) and pyruvate (1 mM) so the substrates
for ATP synthesis are unlikely to be limiting. Nonethe-
less, if axonal ATP synthesis is attenuated or axonal Ca2
+ levels are perturbed, for example through mitochon-
drial injury [13], this could, in principle, account for
axonal demise. Future studies will provide mechanistic
insight.
The reduction in the amount of myelin at 6 dpi was
marked. In this paradigm, cultures were infected at a
time when myelin is just forming (~ DIV 18) and the
paucity of myelin at 6 dpi could reflect failure of myelin
to form normally (dysmyelination) or loss of previously
formed myelin (demyelination). The myelin that
remained often appeared fragmented (Fig. 4) and many
infected PLP/DM20 positive oligodendrocyte cell bodies
lacked myelin sheaths. These observations tend to ex-
clude the possibility that myelination is simply arrested.
Rather, myelin changes probably represent a combin-
ation of the arrest of myelination and the degradation of
previously established sheaths. Whether the latter
(See figure on previous page.)
Fig. 6 Rarely, DRG neurones and Schwann cells are positive for ZIKV in PNS cultures. a-d Micrographs of Ifnar1 knockout (KO) PNS cultures
infected with an MOI of 3.0 for 72 hpi. a Overview of a NeuN and ZIKV-labelled culture to illustrate the low overall level of neuronal infection
(green arrows indicate rare infected cells). Bar: 100 μm. b F480 positive macrophage in which green lipofuscin puncta can be mistaken for ZIKV im-
munostaining as indicated by the level of false ZIKV-positive macrophages observed in mock infected cultures. c ZIKV infected MBP-labelled
Schwann cell (i) and infected and non-infected S100-labelled Schwann cells (ii and iii, respectively). d NeuN-labelled neurones, one of which is in-
fected with ZIKV (green arrow). Bars: 20 μm. e-j Graphs of cell-type specific densities (grey bars) and infected cell densities (black bars) in wild type
(WT) (e-g) and Ifnar 1 KO cultures (h-j). Many macrophages appeared positive for ZIKV in mock-infected cultures, suggesting that many of the
macrophages quantified in (f, g, i and j) represent false positives. Bars represent mean ± SD; n = 3 for all graphs except mock infected wild type
where n = 2
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represents a (i) primary pathology, (ii) secondary conse-
quence of oligodendroglial cell death, (iii) secondary
consequence of axonal loss or (iv) a combination
thereof, remains to be determined.
Importantly, brain white matter is severely compro-
mised in human newborns with congenital ZIKV syn-
drome caused by infection in the first trimester [12].
Chimelli et al. reported an almost complete lack of mye-
lin and oligodendroglia (Olig 2 positive cells) in hemi-
spheric white matter, and only rare myelinated fibres in
the internal capsule and cerebellum in these babies.
Axonal changes including spheroids (swellings) and
Wallerian degeneration were observed in the brainstem
and deep grey nuclei. In contrast, with the exception of
the corticospinal tracts, spinal cord white matter ap-
peared relatively normal. Our in vitro data suggest that
reasons other than susceptibility to injury explain why
spinal cord myelin was preserved in these cases; our
CNS cultures are derived from spinal cord.
Spinal cord motor nerve loss has also been observed
in newborns with congenital ZIKV syndrome [12, 51]. In
contrast, in our spinal-cord derived cultures, neuronal
cell death was unremarkable. In these dissociated cell
cultures, region specific cell fate determinants are absent
or mislocalised and ‘motor neurones’ do not innervate
muscle. As a consequence, these cells are unlikely to ex-
press the full range of cell-type specific gene products
produced in vivo, and this could potentially explain the
different observations; although the short-term nature of
the cultures is likely also a factor. It will be interesting to
ascertain if the small subset of neurones that were in-
fected in our cultures represent a motor neurone
population.
In congenital ZIKV cases examined by Chemelli et al.,
DRGs, dorsal roots and the spinal cord dorsal column
appeared normal [12] (the dorsal roots and dorsal col-
umns carry the peripherally and centrally projecting fi-
bres of DRG neurones). The study’s authors speculated
the sensory system’s DRG neurones might be less sus-
ceptible to ZIKV infection than CNS cells due to their
neural crest origin, as is the case for poliomyelitis and
WNV encephalitis. Schwann cells are also of neural crest
origin, and as demonstrated in the current study, are
also much less susceptible to ZIKV than their CNS
counterparts, which arise directly from the neural tube.
All major neural cell types are susceptible to infection by
ZIKV
We observed ZIKV envelope protein by immunocyto-
chemistry in all major CNS and PNS neural cell types,
however there were marked differences in the suscepti-
bility to infection. Few PNS cells were infected, whilst,
in CNS cultures, oligodendrocytes were most susceptible
and neurones least susceptible. Astrocytes and microglia
displayed a dichotomous infectivity, being only slightly
susceptible after short post infection times but markedly
more vulnerable, relative to other cells, after long post
infection times. Potentially, this could be due to uptake
of infectious debris by these cells (for example, debris
containing infectious viral RNA or virions). However, in
an animal model infected on the day of birth, astrocytes
were the first cell to be targeted, being ZIKV +ve at
4 days post infection [91], and the relevance of our ob-
servation remains to be ascertained.
ZIKV infection is enhanced in absence of a type I
interferon response
The difference in susceptibility to ZIKV infection be-
tween WT and Ifnar1 KO CNS cultures was marked, as
anticipated from previous work [17]. The type I inter-
feron receptor is composed of two polypeptide chains,
IFNAR1 and IFNAR2, and binds all type I interferons;
the archetypal antiviral cytokines. In the CNS, astrocytes
and microglia are thought to be the main source of type
I interferons though there is some evidence that oligo-
dendrocytes and neurones might also produce them
[65]. Given the low level of infection by ZIKV in both
WT and Ifnar1 KO PNS cultures, it was not possible to
ascertain whether type I interferons play a role there
too. The expression of interferon receptors in the PNS
requires clarification.
Animal and cell culture models of flavivirus infection
Animal models and animal-derived cells are widely used for
neuropathogenesis studies with flaviviruses. Among related
neurotropic viruses, JEV has been reported to preferentially
infect developing neurones in primary foetal rat brain cul-
ture [38] and secondary glial activation is involved in neur-
onal death [10]; however others have shown that astrocytes
and microglia are also susceptible to infection [8, 98]. In
mouse models, infection of glial cells and neurones has
been described and the effects of type I interferons were
studied in terms of the complex interplay between virus de-
tection and subsequent responses [3, 9, 11, 24, 30, 35, 37,
44, 59, 61, 62, 76]. It has been speculated that microglia
might act as a reservoir for JEV [84]. Whilst our data sug-
gest ZIKV causes demyelination by direct infection, JEV-
associated demyelination has been linked to auto immunity
[89]. Some of these key observations have been reproduced
in a primate model [60] and human microglia and neu-
rones are also a target for JEV [36, 74, 85]. In the case of
WNV, similar studies on tropism and host responses have
been conducted [69, 81, 93]. Interestingly, astrocytes have
been proposed as persistently infected reservoirs [16] whilst
also mediating protective responses and suppression of
virus (including WNV and ZIKV) replication [44]. Similar
tropism and microglial activation have been described in
primate models of WNV [34, 48], as well as in human cells
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where infection of neurones and glial cells as well as host/in-
flammatory responses to infection were investigated [7, 92].
Conclusions
Few data are available for ZIKV infection of the developing
CNS or PNS, and our study sheds light on these processes.
All cells of the CNS are susceptible to a degree. Recent
studies on ZIKV tropism in human brain cell cultures sug-
gest similar tropism (astrocytes, oligodendrocyte precursor
cells, microglia and to a lesser extent neurones) [46, 70],
demonstrating the relevance of our model. The protein
AXL mediates entry into human microglia and astrocytes
and modulates innate immune responses [50], confirming
previous studies suggesting this host factor is important for
ZIKV infection [45, 63]. However, although Axl mRNA is
expressed in all major neural cell types in the mouse [94],
recent studies suggest that AXL is not important for ZIKV
infection in mice [33, 42]. Nonetheless, as our murine cul-
tures mimic infection of the human nervous system, but in
a readily quantifiable manner, it will be an important tool
for studies of ZIKV pathogenesis.
Additional files
Additional file 1: Figure S1. Cultured E13 spinal cord cells and DRG
explants contain myelinated axons. (a, b) Wild type and Ifnar1 knockout
mouse spinal cord cultures at 28 DIV, labelled with antibodies to
phosphorylated neurofilament (NF) and myelin basic protein (MBP). (c, d)
Wild type and Ifnar1 knockout mouse DRG explant cultures at 28 DIV,
labelled with antibodies to NF and MBP. (TIFF 304742 kb)
Additional file 2: Figure S2. ZIKV-related diminution of CNS myelin
can be observed using markers of various myelin compartments. Anti-
body O4 labels the lipid sulphatide (a, e) whilst Z2 labels myelin oligo-
dendrocyte glycoprotein (MOG) (c, g); both of which are present on
oligodendroglia and their myelin sheaths. a-d Representative images of
mock infected CNS myelinating cultures at DIV 24 show a dense network
of myelinated and non-myelinated axons. e-h In contrast, ZIKV infected
CNS myelinating cultures have a less dense network of neurites (includ-
ing axons). Myelin is markedly reduced and appears fragmented (e, g, h)
and some neuronal cell bodies are filled with phosphorylated heavy and
medium chain neurofilament (arrows in f). Bar: 50 μm. (i) In PNS cultures,
even at 12 dpi there were no overt signs of myelin pathology or cell
death (TIFF 154449 kb)
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